Menu
Fechar
hrs4r
Quiero donar

JORDI MAYNERIS PERXACHS

Nutrición, Eumetabolismo y Salud
Firma
JORDI MAYNERIS-PERXACHS
Posición
Investigador/a Consolidat - R3
Investigador/a Consolidado - R3
Projectes
Publicacions

Projectes

Nutrición, Eumetabolismo y Salud

Ayuda de personal Miquel Servet. Systems biology approach to unravel the pathogenesis of non-alcoholic fatty liver disease (NAFLD)

Codi oficial: MS18/00009 Data inicio:01/01/2019 Data fi: 31/12/2023 Investigador/a principal: JORDI MAYNERIS PERXACHS Organisme finançador: INSTITUTO DE SALUD CARLOS III Ajuda: 202,500 €
Nutrición, Eumetabolismo y Salud

Tryptophan Metabolism: A link between the gut microbiome and cognitive function in obesity and related low-grade chronic inflammation disorders

Codi oficial: PI20/01090 Data inicio:01/01/2021 Data fi: 31/12/2023 Investigador/a principal: JORDI MAYNERIS PERXACHS Organisme finançador: INSTITUTO DE SALUD CARLOS III Ajuda: 171,820 €
Nutrición, Eumetabolismo y Salud

Gut-brain-axis: Targets for improvement of cognition in the elderly

Codi oficial: SMARTAGE Data inicio:01/09/2020 Data fi: 31/08/2024 Investigador/a principal: JOSÉ MANUEL FERNÁNDEZ-REAL LEMOS Organisme finançador: EUROPEAN COMISSION Ajuda: 417,569.76 €
Nutrición, Eumetabolismo y Salud

Dianas terapéuticas y biomarcadores de la medicina de precisión en MAFLD.

Codi oficial: PMP21/00072 Data inicio:01/01/2022 Data fi: 31/12/2025 Investigador/a principal: JOSÉ MANUEL FERNÁNDEZ-REAL LEMOS Organisme finançador: INSTITUTO DE SALUD CARLOS III Ajuda: 141,185 €
Nutrición, Eumetabolismo y Salud

Investigating the influence of gut microbial metabolism on normal age-related cognitive decline. WP4: Multi-omics analyses and integration.

Codi oficial: UKRI Cognitive Decline Data inicio:01/01/2022 Data fi: 31/12/2024 Investigador/a principal: JORDI MAYNERIS PERXACHS Organisme finançador: UK RESEARCH AND INNOVATION (UKRI) Ajuda: 0 €
Nutrición, Eumetabolismo y Salud

Involvement of the gut microbiota-brain cross talk in the loss of eating control

Codi oficial: HR22-00737 Data inicio:01/10/2022 Data fi: 30/09/2025 Investigador/a principal: JOSÉ MANUEL FERNÁNDEZ-REAL LEMOS Organisme finançador: FUND. BANCARIA "LA CAIXA" Ajuda: 374,894.76 €

Publicacions

0

Liver lipopolysaccharide binding protein prevents hepatic inflammation in physiological and pathological non-obesogenic conditions

PHARMACOLOGICAL RESEARCH, 2023, 187, 106562-106562 dx.doi.org/10.1016/j.phrs.2022.106562

Mayneris-Perxachs J, Castells-Nobau A, Arnoriaga-Rodríguez M, Garre-Olmo J, Puig J, Ramos R, Martínez-Hernández F, Burokas A, Coll C, Moreno-Navarrete JM, Zapata-Tona C, Pedraza S, Pérez-Brocal V, Ramió-Torrentà L, Ricart W, Moya A, Martínez-García M, Maldonado R, Fernández-Real JM

Caudovirales bacteriophages are associated with improved executive function and memory in flies, mice, and humans

CELL HOST & MICROBE, 2022, 30, 340 dx.doi.org/10.1016/j.chom.2022.01.013
0

miRNA signatures associated with vulnerability to food addiction in mice and humans

JOURNAL OF CLINICAL INVESTIGATION, 2022, 132 dx.doi.org/10.1172/JCI156281
0

Bidirectional relationships between the gut microbiome and sexual traits

AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2022, 322, 1223-1229 dx.doi.org/10.1152/ajpcell.00116.2022
0

Microbiota alterations in proline metabolism impact depression

CELL METABOLISM, 2022, 34, 681 dx.doi.org/10.1016/j.cmet.2022.04.001
0

Presence of Blastocystis in gut microbiota is associated with cognitive traits and decreased executive function

ISME JOURNAL, 2022, 16, 2181-2197 dx.doi.org/10.1038/s41396-022-01262-3
0

Orally administered Odoribacter laneus improves glucose control and inflammatory profile in obese mice by depleting circulating succinate

Microbiome, 2022, 10, 135-135 dx.doi.org/10.1186/s40168-022-01306-y
0

The role of iron in host-microbiota crosstalk and its effects on systemic glucose metabolism

NATURE REVIEWS ENDOCRINOLOGY, 2022, 18, 683-698 dx.doi.org/10.1038/s41574-022-00721-3
0

Cysteine dioxygenase type 1: A new player in adipose physiology and metabolic health

EBioMedicine, 2022, 86, 104302-104302 dx.doi.org/10.1016/j.ebiom.2022.104302
0

DPP9 as a Potential Novel Mediator in Gastrointestinal Virus Infection

Antioxidants, 2022, 11 dx.doi.org/10.3390/antiox11112177

Formulari de contacte

Conoce el IDIBGI!

 menu